Phase II trial comparing combination treatment with fludarabine and alemtuzumab to fludarabine and rituximab in patients with B-cell chronic lymphocytic leukemia requiring treatment after first line therapy
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2013
At a glance
- Drugs Alemtuzumab; Fludarabine; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2005 New trial record.